|
|
|
| home > white papers > Biosimilars In Emerging Markets: Is It A Level Playing Field? - PRA Health Sciences (PRA) |
|
|
 WHITE PAPERS |
|
PRA Health Sciences (PRA)
|
|
Biosimilars In Emerging Markets: Is It A Level Playing Field?
|
|
Governments, healthcare payers, and social and health reforms, combined
with the increased incidence of conditions such as cancer and diabetes
are paving the way for increased uptake of biologic medicines in
emerging markets. However, expensive biologic medicines can be
prohibitive to many patients, creating a high level of unmet clinical
need. At its best, the global expansion of biosimilars can mean a robust
and steady supply of existing and new drugs reaching far-flung patient
populations, but localized biosimilar drug developments, especially in
China and India, combined with a lack of robust pharmacovigilance
systems, threaten to derail the industry by putting patient health at
risk.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Blood Tests May Prevent Relapse in Breast Cancer Patients
The Royal Marsden NHS Foundation Trust is leading an international
research collaboration to offer blood tests that can identify risk of
relapse in breast cancer patients. The trial will assess whether
personalised blood tests can show which patients will relapse, years
before it’s shown on a scan - treatment can then be altered to try and
prevent relapse from happening. There are currently no effective tests
to establish which patients are at risk of relapse after previous
treatment for breast cancer.
More info >> |
|
 |
White Papers |
 |
|
PROTEIN:PROTEIN INTERACTION ANALYSIS
IBA GmbH
Groth et al., 2007 and Jasencakova et al., 2010
Protein:protein-interactions (PPI) govern almost all important processes
in living organisms. Thus, their rapid and accurate determination and
investigation is a major challenge in life sciences. The extremely
efficient and fast One-STrEP (Twin-Strep) system is suitable for the
isolation of functional protein complexes and subsequent mass
spectrometry analysis leads to the identification of protein complex
components (Junttila et al., 2005) as it is shown in the following
studies.
More info >> |
|
|
|
